Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sildenafil in pancreatic or cholangiocarcinoma cachexia
NCT02106871Phase 1Withdrawn
- Sponsor
- The University of Texas Medical Branch at Galveston
- Start
- Apr 2014
- Primary completion
- Jun 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in cancer cachexia comparing Sildenafil with Placebo (2 arms). Primary endpoints: Lean Body Mass at 4 weeks and Skeletal Muscle Fatigue at 4 weeks. Planned start Apr 2014; status: withdrawn.
02
Drugs
sildenafil
03
Conditions
cancer cachexia
Beyond the preview
Go deeper on NCT02106871.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02106871.